What is the clinical significance of placental lakes seen on a 36‑week ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Placental Lakes at 36 Weeks: Clinical Significance

Placental lakes identified at 36 weeks gestation are generally benign findings with no established clinical significance for adverse pregnancy outcomes, and should not alter routine obstetric management or delivery planning.

Understanding Placental Lakes vs. Lacunae

It is critical to distinguish placental lakes from placental lacunae, as these are fundamentally different entities with vastly different clinical implications 1:

  • Placental lakes are anechoic (sonolucent) areas filled with slow-flowing maternal blood in villous-free areas of normal placental parenchyma. They typically appear from the end of the first trimester onward and vary in size, position, and shape throughout pregnancy.

  • Placental lacunae are pathological spaces formed by distortion of placental lobules within uterine scars, associated with high-volume, high-velocity arterial flows. These are a key ultrasound marker for placenta accreta spectrum disorders and carry serious implications for delivery planning.

The term "placental lakes" in your question likely refers to the benign variant, not lacunae associated with accreta.

Evidence on Clinical Outcomes

Multiple studies demonstrate that placental lakes have no significant association with adverse outcomes:

  • A prospective study of 1,198 pregnancies found placental lakes in 17.8% of second-trimester scans with no significant association with fetal growth restriction (OR 0.68), pre-eclampsia (OR 0.72), placental abruption (OR 1.79), or perinatal mortality (OR 0.94) 2.

  • A 2024 retrospective cohort of 1,052 patients (294 with placental lakes, including 90 with large lakes ≥4 cm) found no differences in pregnancy outcomes including low birthweight, cesarean delivery, fetal growth restriction, preterm birth, or severe preeclampsia 3.

  • A 2017 study examining placental lakes at both 20-22 weeks and 30-32 weeks found no statistically significant associations with hypertensive disease, fetal growth restriction, or low umbilical cord pH 4.

Conflicting Evidence on Large Lakes

One older study (2012) suggested that large placental lakes (>2 cm × 2 cm) identified in the second trimester correlated with small-for-gestational-age fetuses 5. However, this finding has not been consistently replicated in more recent and larger studies 3, 2, and the clinical significance remains uncertain.

Management Recommendations at 36 Weeks

At 36 weeks gestation with placental lakes:

  1. No change in delivery timing: Standard delivery planning should proceed based on other clinical factors. For uncomplicated pregnancies, delivery between 39-40 weeks remains appropriate.

  2. No additional surveillance required: Routine fetal growth monitoring and standard antenatal care are sufficient. There is no evidence supporting increased ultrasound surveillance solely for placental lakes.

  3. Exclude placenta accreta spectrum: If the patient has risk factors (prior cesarean delivery, placenta previa or low-lying placenta), ensure that what is being called "lakes" are not actually lacunae suggestive of accreta. The guidelines recommend transvaginal ultrasound at 36 weeks for patients with persistent low-lying placenta or previa at 32 weeks to inform delivery planning 6.

  4. Document placental location: Confirm the placenta is not previa or low-lying (≥20 mm from internal os), as this would require different management regardless of lakes 6.

Key Clinical Pitfalls to Avoid

  • Do not confuse lakes with lacunae: Lacunae appear as irregular spaces with turbulent flow on Doppler, often with loss of retroplacental clear space and bladder wall abnormalities—these require specialist evaluation for accreta 1.

  • Do not recommend early delivery: There is no evidence supporting delivery before 39 weeks solely due to placental lakes in an otherwise uncomplicated pregnancy.

  • Do not order excessive surveillance: Serial growth scans are not indicated based solely on placental lakes, as the evidence does not support increased risk of growth restriction in most cases 3, 2.

  • Consider context: If placental lakes are noted alongside other concerning findings (thickened placenta, abnormal Doppler, clinical symptoms), investigate those specific issues rather than attributing risk to the lakes themselves.

Bottom Line

Reassure the patient that placental lakes at 36 weeks are a common, benign ultrasound finding that does not require changes to standard obstetric care, delivery timing, or mode of delivery. Proceed with routine management based on other clinical factors, gestational age, and standard obstetric indications 3, 2.

References

Research

Placental lakes vs lacunae: spot the differences.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2024

Research

Presence and Size of Placental Lakes on 20-Week Fetal Anatomy Ultrasound and Obstetrical Outcomes.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2024

Research

The clinical significance of large placental lakes.

European journal of obstetrics, gynecology, and reproductive biology, 2012

Guideline

placenta praevia and placenta accreta: diagnosis and management: green-top guideline no. 27a.

BJOG : an international journal of obstetrics and gynaecology, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.